A bacteriologic and urologic evaluation of sulfamoxole.
D001419:Bacteria / Q000302:isolation & purification*; D001437:Bacteriuria / Q000188:drug therapy; D003556:Cystitis / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011702:Pyelitis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013423:Sulfamoxole / Q000494:pharmacology* / Q000627:therapeutic use*
D013423:Sulfamoxole